Blog

Artificial intelligence.
Human ingenuity.

AlignBio Tournament 2024: Exazyme Achieves Top-Tier Rankings, Highlighting the Power of Its Cutting-Edge Algorithms

Exazyme excels at AlignBio Tournament 2023 and showcases the power of its cutting-edge algorithms. More than 30 teams participated in the first benchmarking event and were asked to show their computationl Protein Prediction and Design capabilities.

Optimized Molecules: A Berlin-based startup uses Artificial Intelligence to enhance the effectiveness of enzymes.

Exazyme shares their vision on optimizing proteins, from enzymes to anti-bodies. Embark on our latest projects and next steps.

Biochemical stars meet Artificial Intelligence: The startup Exazyme uses machine learning to develop blueprints for new enzymes.

Exazyme, initially started as an EXIST Gründerstipendium and Spin-Off from Freie Universität Berlin, has now successfully raised their first VC-investment.

Faces of Future: Dr. Ingmar Schuster

Ingmar Schuster, Exazyme CEO, pioneers AI-driven protein development at Startup Villa, revolutionizing industries for sustainability and efficiency.

Funding for AI-supported protein development: Berlin-based startup Exazyme secures €2 million from AIX Ventures and Atlantic Labs.

Richard Socher, AI expert and AIX Ventures founding partner, anticipates top-tier solutions with Exazyme’s blend of expertise and advanced algorithms.

Season 1

Painful Intelligence: Aapo Hyvärinen on the Concept of Suffering, Drawing Parallels between Humans and AI, and Conclusions for AI Ethics.

Optimized Molecules: A Berlin-based startup uses Artificial Intelligence to enhance the effectiveness of enzymes.

Faces of Future: Dr. Ingmar Schuster

Funding for AI-supported protein development: Berlin-based startup Exazyme secures €2 million from AIX Ventures and Atlantic Labs.

Follow us on LinkedIn for the latest updates